Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Changsheng Bio-technology Co Ltd
  6. Summary
    002680   CNE100001DY7

CHANGSHENG BIO-TECHNOLOGY CO LTD

(002680)
 SummaryNewsCompany 
Company
Changsheng Bio-technology Co., Ltd., formerly Lianyungang Huanghai Machinery Co., Ltd., is a China-based company principally engaged in the research, development, production and sale of human vaccine products. The Company's main products include live attenuated freeze-dried varicella vaccine, freeze-dried human rabies vaccine (Vero cells), freeze-dried live attenuated hepatitis A vaccine, influenza lysis vaccine,... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about CHANGSHENG BIO-TECHNOLOGY CO LTD
2018China issues new delisting rules, to delist vaccine maker Changsheng
RE
2018China's U-turn on market curbs brings back the speculators
RE
2018CHANGSHENG BIO TECHNOLOGY : China sacks six senior officials at food and drug regulator ov..
RE
2018Changsheng Bio-Technology Co., Ltd. Approves Cash Dividend for the Year 2017
CI
2018Changsheng Bio-Technology Proposes Final Cash Dividend for 2017
CI
2017Changchun Huapu Biotechnology Co., Ltd. announced that it expects to receive CNY 40 mil..
CI
2017Changsheng Bio-Technology Co., Ltd. Announces Cash Dividend, Payable on June 13, 2017
CI
2017Changsheng Bio-Technology Co., Ltd. Approves Cash Dividend for the Year 2016
CI
2017Changsheng Bio-Technology Co., Ltd. cancelled the acquisition of an additional 33.72% s..
CI
2017Changsheng Bio-Technology Co., Ltd Proposes Cash Dividend for the Year 2016
CI
2016Changsheng Bio-Technology Co., Ltd Announces 2015 Final Distribution Plan, Payable on 2..
CI
2016Changsheng Bio-Technology Co., Ltd Approves Cash Dividend for the Year 2015
CI
More news
News in other languages on CHANGSHENG BIO-TECHNOLOGY CO LTD
2018Le revirement de Pékin sur les marchés attire les spéculateurs
More news
Managers and Directors
Jun Fang Gao Chairman, General Manager & CFO
Chi Wu Chen Chief Engineer
Dong Guang Ma Independent Director
Yi Shen Independent Director
Hong Xu Independent Director
Sector and Competitors